Effectiveness of Haemophilus influenzae type b vaccination after splenectomy - impact on selected immunological parameters. 2019

Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
a Department of Clinical Immunology and Immunotherapy , Medical University of Lublin , Lublin , Poland.

Splenectomy is a surgery indicated in case of splenic rupture after injury, when there are tumors in the spleen, or as a treatment for certain diseases, such as idiopathic thrombocytopenic purpura and spherocytosis. The aims of the study were to assess the immunological response to the Haemophilus influenzae type b (Hib) vaccine and the post-vaccination changes in lymphocyte subsets and cell activation markers in splenectomized patients and healthy volunteers. Blood samples were collected from 25 patients that had undergone splenectomy and from 15 healthy, non-splenectomized volunteers. All participants received a single dose of Hib vaccine. The concentration of specific Hib antibodies was assessed by an enzyme-linked immunosorbent assay. Selected immune cell populations were evaluated using flow cytometry. The analysis of the antibody titers against Hib showed statistically significant differences in both groups. There was a significantly higher percentage (p = 0.0012) and absolute value (p = 0.0003) of natural killer T (NKT)-like cells (CD3+/CD16+ CD56+) in the study group, compared to the control group. The levels of natural killer (NK) and NKT cells did not change relative to the cause and age of splenectomy. The quantity and percentage of regulatory T (Treg) cells were higher in the study group compared to the control group (p < 0.0001). No significant correlations were found between the time elapsed since splenectomy, the age of the patients, and the Treg levels. Our study showed that spleen resection results in an important deterioration of Treg cells and Th17 cell balance which may contribute to an incomplete immunological response.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D013156 Splenectomy Surgical procedure involving either partial or entire removal of the spleen. Splenectomies
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016667 Bacterial Capsules An envelope of loose gel surrounding a bacterial cell which is associated with the virulence of pathogenic bacteria. Some capsules have a well-defined border, whereas others form a slime layer that trails off into the medium. Most capsules consist of relatively simple polysaccharides but there are some bacteria whose capsules are made of polypeptides. Bacterial Capsule,Capsule, Bacterial,Capsules, Bacterial

Related Publications

Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
February 2003, Lancet (London, England),
Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
November 1992, Lancet (London, England),
Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
July 2013, The Journal of pediatrics,
Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
July 1993, The Medical journal of Australia,
Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
July 1997, Lancet (London, England),
Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
July 1997, Lancet (London, England),
Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
February 1986, The Journal of pediatrics,
Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
May 1986, Lancet (London, England),
Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
September 2001, Revista panamericana de salud publica = Pan American journal of public health,
Ewelina Grywalska, and Dorota Siwicka-Gieroba, and Michał Mielnik, and Martyna Podgajna, and Krzysztof Gosik, and Wojciech Dąbrowski, and Jacek Roliński
January 1996, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!